Mayne denies continuous disclosure breaches in feud with Cosette

M&A 2025-08-06 11:46 pm By Cat Fredenburgh

Mayne Pharma has denied US drug maker Cosette’s claims it breached its continuous disclosure obligations in relation to US FDA concerns about marketing for its Nextstellis contraceptive, as the drug makers spar over their $672 million merger.